|Systematic (IUPAC) name|
|CAS Registry Number|
|Molecular mass||416.5 g/mol|
APP-FUBINACA is an indazole-based synthetic cannabinoid that has been sold online as a designer drug. Pharmacological testing showed APP-FUBINACA to have only moderate affinity for the CB1 receptor, with a Ki of 708 nM, while its EC50 was not tested.
Sweden's public health agency suggested to classify APP-FUBINACA as hazardous substance on March 24, 2015.
- "APP-FUBINACA". Cayman Chemical. Retrieved 15 July 2015.
- Buchler IP et al, INDAZOLE DERIVATIVES. WO 2009/106982
- "Fler ämnen föreslås bli klassade som narkotika eller hälsofarlig vara". Folkhälsomyndigheten. Retrieved 16 July 2015.